Brokerages Set Halozyme Therapeutics, Inc. (NASDAQ:HALO) PT at $53.29
Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) have received an average rating of “Moderate Buy” from the six research firms that are currently covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1 […]
More Stories
J Heath Deneke Sells 1,000 Shares of Summit Midstream Corporation (NYSE:SMC) Stock
Summit Midstream Corporation (NYSE:SMC – Get Free Report) CEO J Heath Deneke sold 1,000 shares of the firm’s stock in...
Incyte Co. (NASDAQ:INCY) Receives Average Rating of “Hold” from Brokerages
Incyte Co. (NASDAQ:INCY – Get Free Report) has been assigned an average recommendation of “Hold” from the twenty ratings firms...
Eaton Co. plc (NYSE:ETN) Receives Average Rating of “Moderate Buy” from Brokerages
Eaton Co. plc (NYSE:ETN – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen...
NextEra Energy Partners, LP (NYSE:NEP) Given Consensus Recommendation of “Hold” by Analysts
NextEra Energy Partners, LP (NYSE:NEP – Get Free Report) has received a consensus rating of “Hold” from the seventeen analysts...
Analysts Set First Solar, Inc. (NASDAQ:FSLR) Target Price at $279.04
Shares of First Solar, Inc. (NASDAQ:FSLR – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the...
Real Good Food Company, Inc. Holds Special Meeting of StockholdersOn December 20, 2024, Real Good Food Company, Inc. (NASDAQ: RGF) conducted a virtual special meeting of stockholders to address key proposals. The meeting welcomed in-person and proxy
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For...